Reaction
Colon Cancer Recurrent reporting signals
As of the last recalculation, Colon Cancer Recurrent appears in 270 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is REGORAFENIB (PRR 135.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Regorafenib | 19 | 135.6 | 135.9 |
| Panitumumab | 17 | 89.2 | 89.3 |
| Irinotecan Hydrochloride | 6 | 36.8 | 36.8 |